Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1990-05-30 to 1990-10-29
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline-conform study under GLP without deviations.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Deviations:
yes
Principles of method if other than guideline:
Summary of protocol amendments:
The challenge skin reactions with score 1 or more were considered to be a sign of sensitization, instead of challenge skin reactions with score 2 or more as noted in the protocol. This change in normal evaluation procedure was implemented as a result of the clear difference i n response between control and experimental animals.
GLP compliance:
yes
Type of study:
Buehler test

Test material

Constituent 1
Chemical structure
Reference substance name:
Dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)
EC Number:
407-230-4
EC Name:
Dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)
Cas Number:
126637-70-5
Molecular formula:
Hill formula: C32 H16 Cu2 Li2 N6 Na2 O16 S4 CAS formula: C32 H16 Cu2 N6 O16 S4. 2Li 2Na
IUPAC Name:
dicopper(2+) dilithium(1+) disodium 4,4'-bis[2-(8-amino-1-oxido-3,6-disulfonatonaphthalen-2-yl)diazen-1-yl]-[1,1'-biphenyl]-3,3'-bis(olate)

In vivo test system

Test animals

Species:
guinea pig
Strain:
Himalayan
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
water
Remarks:
Milli-Q water
Concentration / amount:
Induction phase:
Experimental animals were exposed on day 1 with 0.5 ml of the test substance suspended to 50 % (wlw) in milli-RO water. From day 3 onwards, the test substance concentration was decreased to 25 % ( w /w ) , since the 50 % was too viscous.
Challange expoure:
Concentration of test material and vehicle used for 1st. challenge: 25%
Rechallenge: 25%, 10%, 5% (w/w) in Milli-Ro water
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
water
Remarks:
Milli-Q water
Concentration / amount:
Induction phase:
Experimental animals were exposed on day 1 with 0.5 ml of the test substance suspended to 50 % (wlw) in milli-RO water. From day 3 onwards, the test substance concentration was decreased to 25 % ( w /w ) , since the 50 % was too viscous.
Challange expoure:
Concentration of test material and vehicle used for 1st. challenge: 25%
Rechallenge: 25%, 10%, 5% (w/w) in Milli-Ro water
No. of animals per dose:
Number of animals in test group: 20 Number of animals in negative control group: 10
Challenge controls:
The challenge sites of experimental and control animals were assessed for redness and swelling 24 and 48 hours after removal of the dressings.
Positive control substance(s):
yes
Remarks:
formaldehyde

Results and discussion

Positive control results:
Clearly positive results were observed in the experimental animals after the challenge with 0.5% (w/w) FORMALDEHYDE in milli-RO water. experiment carried out once a year.

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
25 %
No. with + reactions:
14
Total no. in group:
20
Clinical observations:
Very small crusts.
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25 %. No with. + reactions: 14.0. Total no. in groups: 20.0. Clinical observations: Very small crusts..
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
25 %
No. with + reactions:
12
Total no. in group:
20
Clinical observations:
Very small crusts. Oedema under crusts, no erythema observed.
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 12.0. Total no. in groups: 20.0. Clinical observations: Very small crusts. Oedema under crusts, no erythema observed..
Reading:
rechallenge
Hours after challenge:
24
Group:
test chemical
Dose level:
25 %
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
Very small crusts and swelling underneath, no erythema observed.
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 25 %. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: Very small crusts and swelling underneath, no erythema observed..
Reading:
rechallenge
Hours after challenge:
48
Group:
test chemical
Dose level:
25 %
No. with + reactions:
4
Total no. in group:
20
Clinical observations:
Very small crusts and swelling underneath, no erythema observed.
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 4.0. Total no. in groups: 20.0. Clinical observations: Very small crusts and swelling underneath, no erythema observed..
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
rechallenge
Hours after challenge:
24
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
rechallenge
Hours after challenge:
48
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information
Conclusions:
A 25 % solution of the substance resulted in a sensitization rate of 20 % in guinea pig. The substance therefore should be labelled as a skin sensitizer.